Genomics and biobank data

Genomic and biobank data is uniquely powerful for research and uniquely sensitive. It can only be accessed under strict legal, ethical and governance conditions. This guide explains the landscape responsibly.

A cautious starting point

Genetic data is special-category data with the highest sensitivity, since it is inherently identifying and shared across relatives. Access is governed by law, ethics committees and data-access frameworks, and everything here is subject to those requirements.

What it offers

Genomics and biobank data enable research into disease, drug response and population health. The value is scientific; the constraints are correspondingly strict.

Controlled access

Such data is typically available only through controlled-access mechanisms: approved researchers, defined purposes, secure environments and oversight. Open release of raw genomic data is generally not appropriate.

Privacy and ethics

Re-identification risk is intrinsic, and consent, ethics approval and governance are mandatory. Aggregated, summary and synthetic data are safer routes for many purposes.

Sourcing considerations

Legal basis, ethics and access agreements come first, and provenance and governance documentation are essential. This is a domain where doing it correctly matters more than doing it quickly.

In a managed model

A managed partner can navigate controlled-access frameworks and, where appropriate, source aggregated or synthetic data, always within legal and ethical bounds.

Inherently identifying

Genetic data is the most sensitive special-category data, since it is inherently identifying and shared across relatives, so access is via controlled-access frameworks, not open release. Consent, ethics approval and governance are mandatory, and aggregated, summary or synthetic data are safer routes for many purposes.

Doing it correctly

Legal basis, ethics and access agreements come before anything, and provenance and governance documentation are essential. This is a domain where doing it correctly matters far more than doing it quickly, and a managed approach navigates the access frameworks within strict legal and ethical bounds.

Sources & further reading

• EUR-Lex: Regulation (EU) 2016/679 (GDPR), genetic data.
• European Health Data Space (EHDS) proposals.
• GA4GH: data-access and governance frameworks.
• National biobank and research-ethics rules.